PHOENIX, AZ—January 18, 2018 – The Arizona Health Care Cost Containment System (AHCCCS) received 1115 Waiver Amendment approval from the Centers for Medicare and Medicaid Services (CMS) to implement community engagement requirements for some able bodied AHCCCS members ages 19 to 49, and to limit retroactive coverage for some applicants to the beginning of the month in which the Medicaid application is filed. Continue reading→

New technology allows better tracking of potentially deadly infectionContinue reading→

The Mayo Clinic-ASU MedTech Accelerator, a collaboration between Mayo Clinic and Arizona State University that is designed specifically for medical device and health care technology companies, is now accepting applications.Continue reading→

Chief Executive Officer TJ Johnson to assume role of Executive Chairman at the end of first quarter 2019

John Lubniewski, President and Chief Operating Officer, appointed as successorContinue reading→

Researchers at the University of Arizona have discovered a protein that prevents mosquitoes from hatching, opening the possibility of developing new drugs that could act as birth control for mosquito populations.Continue reading→

Critical Path Institute (C-Path) and Flagstaff, Arizona-based TGen North — the Pathogen and Microbiome Division of the Translational Genomics Research Institute (TGen) — have received a Phase 1 Concept Validation grant from the Flinn Foundation, of $400,000 over 12 months, to develop and pilot a framework enabling the state institutions to be more responsive to antimicrobial resistance. Working as partners in this venture, C-Path and TGen, an affiliate of City of Hope, will solidify requirements among multiple stakeholders and develop an integrated deployment plan for a statewide Healthcare Associated Antimicrobial Resistant Microbe genomic surveillance system, dubbed Prevent HAARM.Continue reading→

In a new study, researchers at the Biodesign Institute explore a safe and simple treatment for one of the most devastating and perplexing afflictions: Alzheimer’s disease.Continue reading→

Jim Ratcliff shares what is like  expanding into China during a Trade War.Continue reading→